![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 4, 1938-1945, 02, 1990
SS Simons Jr, PK Chakraborti and AH Cavanaugh
Steroid Hormones Section, National Institute of Diabetes and Digestive and Kidney Diseases, Laboratory of Analytical Chemistry, National Institutes of Health, Bethesda, Maryland 20892.
Low concentrations of arsenite, but not arsenate, and Cd2+ blocked steroid binding to the glucocorticoid receptors of HTC cells. Inhibition by arsenite was faster and occurred at lower concentrations than for Cd2+. Half-maximal inhibition of [3H]dexamethasone binding was seen after a 30-min preincubation with approximately 7 microM arsenite. The effect of arsenite and of Cd2+ appears to be mediated by a reaction with vicinal dithiols of the receptor as shown by (a) the reversal of arsenite inhibition by much lower concentrations of dithiothreitol (approximately 0.1 mM) than of beta-mercaptoethanol (approximately 10 mM); (b) the ability of both arsenite and Cd2+ to block [3H]dexamethasone 21-mesylate labeling of receptors but not of other thiol-containing proteins; and (c) the known selectivity of arsenite and of Cd2+ for reactions with vicinal dithiols. Arsenite forms a tight complex with these vicinal dithiols since the removal of loosely associated arsenite by gel exclusion chromatography did not reverse the inhibition of steroid binding. The effect of other ions on steroid binding was also examined. Half-maximal inhibition of binding occurred with approximately 5 microM selenite, whereas up to 300 microM Zn2+ was without effect. Much higher concentrations of arsenite were required for effects on unactivated and activated complexes. Arsenite slowly induced a loss of unactivated complexes but rapidly inhibited a portion of the DNA binding of activated complexes. Any effect on activation occurred at arsenite concentrations equal to or higher than those that inhibited DNA binding. In contrast, Cd2+ concentrations similar to those that block steroid binding caused a biphasic loss of unactivated complexes and a marginal loss of activated complexes. This is the first report of effects of arsenite on glucocorticoid receptors. These results confirm directly our earlier hypothesis that steroid binding to rat glucocorticoid receptors involves a vicinal dithiol (Miller, N. R., and Simons, S. S., Jr. (1988) J. Biol. Chem. 263, 15217-15225) and show that arsenite is a potent new reagent for probing receptor structure and function.
This article has been cited by other articles:
![]() |
K. Nohara, K. Ao, Y. Miyamoto, T. Suzuki, S. Imaizumi, Y. Tateishi, S. Omura, C. Tohyama, and T. Kobayashi Arsenite-Induced Thymus Atrophy is Mediated by Cell Cycle Arrest: A Characteristic Downregulation of E2F-Related Genes Revealed by a Microarray Approach Toxicol. Sci., February 1, 2008; 101(2): 226 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Davey, J. E. Bodwell, J. A. Gosse, and J. W. Hamilton Arsenic as an Endocrine Disruptor: Effects of Arsenic on Estrogen Receptor-Mediated Gene Expression In Vivo and in Cell Culture Toxicol. Sci., July 1, 2007; 98(1): 75 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kitana, S. J. Won, and I. P. Callard Reproductive Deficits in Male Freshwater Turtle Chrysemys picta from Cape Cod, Massachusetts Biol Reprod, March 1, 2007; 76(3): 346 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bonzo, S. Chen, A. Galijatovic, and R. H. Tukey Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest Mol. Pharmacol., April 1, 2005; 67(4): 1247 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Novillo, S.-J. Won, C. Li, and I. P. Callard Changes in Nuclear Receptor and Vitellogenin Gene Expression in Response to Steroids and Heavy Metal in Caenorhabditis elegans Integr. Comp. Biol., January 1, 2005; 45(1): 61 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vetillard and T. Bailhache Cadmium: An Endocrine Disrupter That Affects Gene Expression in the Liver and Brain of Juvenile Rainbow Trout Biol Reprod, January 1, 2005; 72(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al. Arsenic-Related Chromosomal Alterations in Bladder Cancer J Natl Cancer Inst, November 20, 2002; 94(22): 1688 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. McLachlan Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting Chemicals Endocr. Rev., June 1, 2001; 22(3): 319 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stoica, E. Pentecost, and M. B. Martin Effects of Arsenite on Estrogen Receptor-{alpha} Expression and Activity in MCF-7 Breast Cancer Cells Endocrinology, October 1, 2000; 141(10): 3595 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Guével, F.G. Petit, P. L. Goff, R. Métivier, Y. Valotaire, and F. Pakdel Inhibition of Rainbow Trout (Oncorhynchus mykiss) Estrogen Receptor Activity by Cadmium Biol Reprod, July 1, 2000; 63(1): 259 - 266. [Abstract] [Full Text] |
||||
![]() |
A. Stoica, B. S. Katzenellenbogen, and M. B. Martin Activation of Estrogen Receptor-{alpha} by the Heavy Metal Cadmium Mol. Endocrinol., April 1, 2000; 14(4): 545 - 553. [Abstract] [Full Text] |
||||
![]() |
J. S. Hanas, J. S. Rodgers, J. A. Bantle, and Y.-G. Cheng Lead Inhibition of DNA-Binding Mechanism of Cys2His2 Zinc Finger Proteins Mol. Pharmacol., November 1, 1999; 56(5): 982 - 988. [Abstract] [Full Text] |
||||
![]() |
C. Meplan, K. Mann, and P. Hainaut Cadmium Induces Conformational Modifications of Wild-type p53 and Suppresses p53 Response to DNA Damage in Cultured Cells J. Biol. Chem., October 29, 1999; 274(44): 31663 - 31670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sidransky and E. Verney Influence of Lead Acetate and Selected Metal Salts on Tryptophan Binding to Rat Hepatic Nuclei Toxicol Pathol, July 1, 1999; 27(4): 441 - 447. [Abstract] [PDF] |
||||
![]() |
W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text] |
||||
![]() |
M. Xu, P. K. Chakraborti, M. J. Garabedian, K. R. Yamamoto, and S. S. Simons Jr. Modular Structure of Glucocorticoid Receptor Domains Is Not Equivalent to Functional Independence. STABILITY AND ACTIVITY OF THE STEROID BINDING DOMAIN ARE CONTROLLED BY SEQUENCES IN SEPARATE DOMAINS J. Biol. Chem., August 30, 1996; 271(35): 21430 - 21438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Stancato, A. M. Silverstein, C. Gitler, B. Groner, and W. B. Pratt J. Biol. Chem., April 12, 1996; 271(15): 8831 - 8836. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |